Torrent Pharmaceuticals has announced the expansion of its flagship Shelcal brand into the growing nutrition segment with the launch of Shelcal Total— a scientifically formulated adult nutrition supplement powder.

Shelcal, a leading calcium supplement brand, has seen a steady evolution since Torrent Pharma acquired it in 2013. The brand has since expanded its portfolio with consumer-friendly innovations such as Shelcal Pro Gummies and Shelcal Pro Kids Gummies, strengthening its relevance across age groups.

The launch of Shelcal Total now marks the brand’s evolution into a modern, consumer-focused nutrition portfolio.  

Speaking on the launch, Amal Kelshikar, Chief Commercial Officer – India Business at Torrent Pharma, said, “India is facing a growing nutrition gap driven by lifestyle changes, poor dietary habits, and rising stress levels — all of which contribute to deficiencies across age groups.”

“As health awareness increases and more adults are in need of convenient holistic nutrition, the demand for trusted, convenient solutions is only accelerating. Shelcal Total is our answer to that need — a science-backed, great-tasting supplement that makes comprehensive daily nutrition more accessible and easier to adopt, while upholding Shelcal’s long-standing credibility and consumer trust,” he said.

Certified nutritionist Nmami Agarwal pointed out that many Indian adults, particularly those over the age of 30, often face interconnected nutritional deficiencies that can affect bone density, muscle mass, and joint mobility

"Shelcal Total has comprehensive approach with nutrients to addresses the common prevalent deficiencies, even beyond bone and joint health. For busy professionals and aging adults who struggle to meet their nutritional needs through diet alone, this is a practical, science-backed solution due to its multitude of nutrients to help fulfil required RDA," said Agarwal.

The launch comes at a pivotal time for India’s nutrition supplements market is witnessing robust growth. Valued at USD 42.97 billion in 2024, the market is projected to grow at a CAGR of 8.1 percent through 2030. Powdered supplements account for nearly 38 percent of the market.

Torrent Pharmaceuticals, the flagship company of the Torrent Group, reported annual revenues of over INR 11,500 crore.

The company is a leader in the therapeutics segments of cardiovascular (CV), gastro intestinal (GI), central nervous system (CNS) and cosmo-dermatology.

With presence in more than 50 countries, Torrent Pharmaceuticals has eight manufacturing facilities, five of which are approved by the USFDA.